Examples of 'steatohepatitis' in a sentence
Meaning of "steatohepatitis"
steatohepatitis (noun): Steatohepatitis is a medical term used to describe a type of liver disease characterized by inflammation and fatty infiltration of the liver tissue
Show more definitions
- A form of hepatitis characterized by an accumulation of fat.
How to use "steatohepatitis" in a sentence
Basic
Advanced
steatohepatitis
Factors associated with steatohepatitis were evaluated using logistic regression.
Steatohepatitis can progress to cirrhosis and can be associated with hepatocellular carcinoma.
However they can often present the disease that is known as nonalcoholic steatohepatitis.
Treatment for steatohepatitis tends to be focused on eliminating the underlying cause.
Three protocols were required to accurately detect steatohepatitis and two for fibrosis detection.
Metabolic steatohepatitis represents a stage of development of metabolic hepatic steatosis in some people.
Hepatic steatosis is a risk factor for progressive liver disease including steatohepatitis and cirrhosis.
Some instances of steatohepatitis progress to a deadly form of cancer known as hepatocellular carcinoma.
Mipomersen treatment can cause liver enzyme elevations and hepatic steatosis and this may induce steatohepatitis.
Nonalcoholic steatohepatitis is progressive and may finally progress to cirrhosis and hepatocellular carcinoma.
The Effectiveness of combination therapy in the treatment of nonalcoholic steatohepatitis.
Fatty liver may progress to steatohepatitis and cirrhosis with the attendant morbidity and mortality.
NAFLD is divided into simple fatty liver and nonalcoholic steatohepatitis.
Steatohepatitis would make his AST and ATL levels rise.
When inflammation is present it is referred to as alcoholic steatohepatitis and nonalcoholic steatohepatitis NASH.
See also
This result indicates that Compound B is useful as a therapeutic agent for nonalcoholic steatohepatitis.
No differences were seen according age, gender, steatohepatitis or fibrosis distribution.
Vitamin E and vitamin C treatment improves fi brosis is patients with nonalcoholic steatohepatitis.
Non-alcoholic steatohepatitis is fatty liver disease due to causes other than alcohol.
The NAFLD can be hepatic steatosis or steatohepatitis.
The above-described steatohepatitis model animals of the present invention subsequently develop liver cirrhosis.
Biomarkers from subjects with Steatosis compared to Steatohepatitis subjects.
Nonalcoholic steatohepatitis ( NASH ) is a common and potentially severe form of liver disease.
Role of alcohol metabolism in non-alcoholic steatohepatitis.
Nonalcoholic steatohepatitis ( NASH ) is the accumulation of fat in the liver accompanied by hepatic inflammation.
In some embodiments, the metabolic disorder is steatohepatitis.
No complaints of pain . Steatohepatitis would make his AST and ATL levels rise.
In one embodiment, the liver disease is alcoholic steatohepatitis.
The nonalcoholic steatohepatitis ( nash ) has been linked to insulin resistance.
The role of bariatric surgery in non-alcoholic steatohepatitis.
Its progression to non-alcoholic steatohepatitis ( nash ) is characterized by inflammation and hepatocytes injury.
In one embodiment, the liver disease is nonalcoholic steatohepatitis.
Herein, " amelioration " means that the symptoms of steatohepatitis are alleviated or restored to normal.
A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis.
Fatty . liver and steatohepatitis.
Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis.
A method of monitoring progression / regression of steatohepatitis in a subject comprising,.
Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin E in nonalcoholic steatohepatitis.
A method of evaluating a medicinal substance for efficacy against steatohepatitis amelioration, which comprises the steps of,.
This substitution has also been linked to increased frequency of non-alcoholic steatohepatitis.
Improved nonalcoholic steatohepatitis aft er 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone.
In certain such examples, the subject has steatohepatitis.
The pathological findings of steatohepatitis include, for example, the above-described pathological findings ( pathological morphologies ).
In certain such embodiments, the subject has steatohepatitis.
Methods of treating non-alcoholic steatohepatitis ( NASH ) using cysteamine products.
Metformin in the treatment of patients with non-alcoholic steatohepatitis.
Non-alcoholic steatohepatitis ( NASH ) is the hepatic manifestation of metabolic syndrome.
As a result, the present inventors successfully developed steatohepatitis in mice.
In the more serious form, non-alcoholic steatohepatitis or NASH, inflammation and liver scarring are present.
Mitochondrial dysfunction also plays a key role in non-alcoholic steatohepatitis.
